Pieter‐Jan Cuyle

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease

Delphine Labaere, Annick Smismans, August Van Olmen et al. · United European Gastroenterology Journal · 2014 · 142 citations · Full text

Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy

Maarten Albersen, Steven Joniau, Hendrik Van Poppel et al. · Nature Clinical Practice Urology · 2007 · 46 citations

Urological Research, Urology, Pathogenesis +5

BEACON CRC study safety lead-in (SLI) in patients with <i>BRAF</i>^V600E metastatic colorectal cancer (mCRC): Efficacy and tumor markers.

Eric Van Cutsem, Pieter‐Jan Cuyle, Sanne C.F.A. Huijberts et al. · Journal of Clinical Oncology · 2018 · 37 citations

Cancer Management, Immunology, Pathology +16

Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial

Philip Roelandt, Ingrid Demedts, Hilde Willekens et al. · Endoscopy · 2019 · 28 citations · Full text